Development of DNA Topoisomerase-Related Therapeutics: A Short Perspective of New Challenges

E-ISSN： 1875-5968|4|4|335-345

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.4, 2004-07, pp. : 335-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

By Vassal G. Pondarre C. Cappelli C. Terrier-Lacombe M.J. Boland I. Morizet J. Benard J. Venuat A.M. Ardouin P. Hartmann O. Gouyette A.

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2011-2015

Elsevier

Access to resources Recommend Favorite

Design of New Anti-Cancer Agents Based on Topoisomerase Poisons Targeted to Specific DNA Sequences

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 1, Iss. 3, 2001-01 ,pp. : 219-235

Bentham Science Publishers

Access to resources Recommend Favorite

Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium ‘Breast Cancer – the Development and Validation of New Therapeutics’

By Lippman Marc

Breast Cancer Research and Treatment, Vol. 90, Iss. 1, 2005-03 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Etoposide: four decades of development of a topoisomerase II inhibitor

By Hande K.R.

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1514-1521

Elsevier

Access to resources Recommend Favorite

RNA interference therapeutics for cancer: Challenges and opportunities (Review)

By Bora Roop Singh Gupta Dikshi Mukkur Trilochan Kanwaljit Singh Saini Kulvinder Singh

Molecular Medicine Reports, Vol. 6, Iss. 1, 2012-07 ,pp. : 9-15

Spandidos Publications

Access to resources Recommend Favorite